Cellmid Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellmid Limited with three other
companies in this sector in Australia:
sales of 3.24 million Australian Dollars [US$2.50 million]
of which 64%
Benitec Biopharma Limited
(4.05 million Australian Dollars [US$3.13 million]
Innate Immunotherapeutics Ltd
(2.29 million Australian Dollars [US$1.77 million]
Cellmid Limited reported sales of A$3.39 million (US$2.62 million)
June of 2016.
increase of 72.1%
versus 2015, when the company's sales were A$1.97 million.